No Data
No Data
Addus HomeCare Is Maintained at Buy by TD Cowen
Addus HomeCare Is Maintained at Buy by TD Cowen
TD Cowen Maintains Buy on Addus HomeCare, Raises Price Target to $119
TD Cowen analyst Ryan Langston maintains Addus HomeCare (NASDAQ:ADUS) with a Buy and raises the price target from $105 to $119.
Express News | Arex Capital Expresses Disappointment in Enhabit’s Strategic Review Conclusion
Express News | Addus Homecare Corp : TD Cowen Raises Target Price to $119 From $105
Express News | Addus Homecare Corp : Raymond James Raises Target Price to $115 From $105
Here's Why We Think Addus HomeCare (NASDAQ:ADUS) Is Well Worth Watching
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks' without any revenue, let alone profit.